Literature DB >> 220534

Identification of human glandular kallikrein in the beta cell of the pancreas.

O K ole-MoiYoi, G S Pinkus, J Spragg, K F Austen.   

Abstract

To determine the cellular localization of glandular kallikrein in the human pancreas, immunohistochemical studies were performed with a monospecific antibody against the antigenically identical urinary kallikrein (urokallikrein). The localization of glandular pancreatic kallikrein to the beta cells of the islets was the same as that of insulin in normal human pancreas and in two islet-cell tumors. When beta cells were lacking in islet-cell tumors or in the pancreas of a patient with juvenile-onset diabetes, kallikrein antigen was not detectable. Anti-urokallikrein absorbed with purified urinary or pancreatic kallikrein no longer identified a pancreatic antigen, whereas absorption with insulin had no effect. The beta-cell localization of human pancreatic kallikrein, an endopeptidase that, in concert with carboxypeptidase B, converts bovine proinsulin to a polypeptide with the electrophoretic mobility of insulin, suggests that pancreatic kallikrein may be involved in the physiologic activation of proinsulin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 220534     DOI: 10.1056/NEJM197906073002301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  9 in total

Review 1.  Molecular biology of tissue kallikrein.

Authors:  R J MacDonald; H S Margolius; E G Erdös
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

Review 2.  Secretory granules.

Authors:  J C Hutton
Journal:  Experientia       Date:  1984-10-15

3.  Biochemical and clinical implications of proinsulin conversion intermediates.

Authors:  B D Given; R M Cohen; S E Shoelson; B H Frank; A H Rubenstein; H S Tager
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

4.  Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration.

Authors:  Isobel A Scarisbrick; Rachel Linbo; Alexander G Vandell; Mark Keegan; Sachiko I Blaber; Michael Blaber; Diane Sneve; Claudia F Lucchinetti; Moses Rodriguez; Eleftherios P Diamandis
Journal:  Biol Chem       Date:  2008-06       Impact factor: 3.915

5.  Pentamidine, a new diabetogenic drug in laboratory rodents.

Authors:  P Saï; D Boillot; C Boitard; M Debray-Sachs; G Reach; R Assan
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

6.  Kallikrein-induced uterine contraction independent of kinin formation.

Authors:  J Chao; J Buse; K Shimamoto; H S Margolius
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

7.  Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.

Authors:  Alexander G Vandell; Nadya Larson; Gurunathan Laxmikanthan; Michael Panos; Sachiko I Blaber; Michael Blaber; Isobel A Scarisbrick
Journal:  J Neurochem       Date:  2008-09-06       Impact factor: 5.372

8.  Direct action of rat urinary kallikrein on rat kidney to release renin.

Authors:  S Suzuki; R Franco-Saenz; S Y Tan; P J Mulrow
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

9.  Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas.

Authors:  Maryam Alsadat Hashemipour; Fatemeh Sadat Fatah; Mohammad Javad Ashraf; Mehrnaz Tahmasebi
Journal:  Iran J Pathol       Date:  2016
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.